1. Home
  2. EXFY vs VTYX Comparison

EXFY vs VTYX Comparison

Compare EXFY & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXFY
  • VTYX
  • Stock Information
  • Founded
  • EXFY 2008
  • VTYX 2018
  • Country
  • EXFY United States
  • VTYX United States
  • Employees
  • EXFY N/A
  • VTYX N/A
  • Industry
  • EXFY Computer Software: Prepackaged Software
  • VTYX Medicinal Chemicals and Botanical Products
  • Sector
  • EXFY Technology
  • VTYX Health Care
  • Exchange
  • EXFY Nasdaq
  • VTYX Nasdaq
  • Market Cap
  • EXFY 165.4M
  • VTYX 154.9M
  • IPO Year
  • EXFY 2021
  • VTYX 2021
  • Fundamental
  • Price
  • EXFY $1.39
  • VTYX $8.67
  • Analyst Decision
  • EXFY Strong Buy
  • VTYX Strong Buy
  • Analyst Count
  • EXFY 3
  • VTYX 4
  • Target Price
  • EXFY $4.75
  • VTYX $14.25
  • AVG Volume (30 Days)
  • EXFY 412.7K
  • VTYX 10.0M
  • Earning Date
  • EXFY 11-06-2025
  • VTYX 11-06-2025
  • Dividend Yield
  • EXFY N/A
  • VTYX N/A
  • EPS Growth
  • EXFY N/A
  • VTYX N/A
  • EPS
  • EXFY N/A
  • VTYX N/A
  • Revenue
  • EXFY $144,251,000.00
  • VTYX N/A
  • Revenue This Year
  • EXFY $5.45
  • VTYX N/A
  • Revenue Next Year
  • EXFY $2.56
  • VTYX N/A
  • P/E Ratio
  • EXFY N/A
  • VTYX N/A
  • Revenue Growth
  • EXFY 4.13
  • VTYX N/A
  • 52 Week Low
  • EXFY $1.35
  • VTYX $0.78
  • 52 Week High
  • EXFY $4.13
  • VTYX $9.50
  • Technical
  • Relative Strength Index (RSI)
  • EXFY 26.67
  • VTYX 72.15
  • Support Level
  • EXFY $1.63
  • VTYX $7.80
  • Resistance Level
  • EXFY $1.66
  • VTYX $9.46
  • Average True Range (ATR)
  • EXFY 0.07
  • VTYX 0.93
  • MACD
  • EXFY -0.01
  • VTYX 0.24
  • Stochastic Oscillator
  • EXFY 10.98
  • VTYX 86.95

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: